This page lists all known medications that could potentially lead to 'Thrombotic microangiopathy' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Overall, 55 patients were diagnosed with thrombotic ...

Transplant-associated thrombotic microangiopathy (TA-TMA) is an early complication of hematopoietic cell transplantation (HCT). A high mortality rate is documented in patients who are refractory to ...

The labeling for Lamisil (terbinafine hydrochloride) Tablets and Oral Granules has been updated to include a new warning regarding the risk of thrombotic microangiopathy. The labeling for Lamisil ...

Thrombotic microangiopathy is a serious complication of hematopoietic stem cell transplant (HSCT). The etiology and pathogenesis of transplant-associated thrombotic microangiopathy (TA-TMA) following ...

Kidney involvement is a common finding in patients with systemic lupus erythematosus (SLE) and with antiphospholipid syndrome (APS). Malignant hypertension (MHT) is a rare but still present ...

Thrombotic microangiopathy further decreases patient and renal survival in patients with SLE. Patients with systemic lupus erythematosus (SLE) with thrombotic microangiopathy (TMA) have lower ...

Treatments for asthma, chronic rhinosinusitis with nasal polyps, dyslipidemia, Cushing syndrome, gonorrhea, HSCT-associated thrombotic microangiopathy, marginal zone lymphoma, motion sickness, ...

Sacubitril/valsartan may be a better treatment option compared with ACEi/ARBs for patients with malignant hypertension-associated thrombotic microangiopathy. Kidney recovery is better when thrombotic ...

Shown are renal-biopsy specimens obtained from four patients receiving recombinant interferon beta therapy in South Scotland in whom thrombotic microangiopathy was diagnosed during an 18-month period ...

We present a 41-year-old man 11 months after a second KTx, with end-stage renal disease in the course of immunoglobulin (Ig) A nephropathy admitted to the transplantation center for the assessment of ...

SEATTLE, April 2, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced positive data using OMS721, the lead human monoclonal antibody in Omeros' mannan-binding lectin-associated ...